Cardinal Health — Oct 30, 2025 release
Fiscal 2026 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000721371-25-000128
Showing in the filing
Non-GAAP adjusted free cash flow outlook
“$3.0 to $3.5 billion”
Period
FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 9
Non-GAAP adjusted free cash flow outlook for FY2026
“$3.0 to $3.5 billion”
Non-GAAP diluted EPS for FY2026
“$9.65 to $9.85 (+17% to +20% growth)”
Non-GAAP diluted EPS attributable to Cardina… for FY2026
“$9.65 to $9.85”
Pharmaceutical and Specialty Solutions segme… for FY2026
“16% to 19%”
Other segment profit growth for FY2026
“29% to 31%”
Interest and Other expense for FY2026
“~$325 million”
Diluted weighted average shares outstanding for FY2026
“~238 million”
Capital expenditures for FY2026
“$600 million to $650 million”
BioPharma Solutions business growth expectat… for FY2026
“over 30%”
Exhibit 99.1 · the passage around this item
… earlier in the release
pany's operating segments; non-GAAP diluted EPS increased 36% to $2.55 • Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance 2 to $9.65 to $9.85 and fiscal year 2026 non-GAAP adjusted free cash flow outlook to $3.0 to $3.5 billion • Cardinal Health anticipates completing the acquisition of Solaris Health in early November DUBLIN, Ohio, October 30, 2025 - Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2026 revenues of $64 billion, an increase of 22% from the first quarter of fiscal year 2025. First quarter GAAP operating earnings increased 18% to $668 million and GAAP diluted earnings per share (EPS) increased 11% to $1.88. First quarter non-GAAP operating earnings increased 37% to $857 million, driven by segment profit growth across all five of the company's operating segments. Non-GAAP diluted EPS increased 36% to $2.55, reflecting the increase in non-GAAP operating earnings, a lower share count and a lower effective tax rate, partially offset by an increase in interest and other expense due to financing costs related to announced acquisitions. “We are pleased with our strong broad-based operational and financial performance to begin fiscal 2026,” said Jason Hollar, CEO of Cardinal Health. “This outstanding first quarter reflects our focused execution across each of our operating segments and provides a solid foundation as we carry forward. As a result, we are raising our fiscal 2026
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.